Members
Charles Peloquin Pharm.D.
Research News
Extensively drug-resistant Shigella infections are increasing. Here’s what you need to know.
A UF researcher with expertise in infectious bacteria offers commentary and perspective on extensively drug-resistant Shigella infections following a recent CDC warning.
UF’s EPI supports testing for new technology to kill space microbes
UF’s EPI is partnering with Gainesville-based tech company SurfPlasma, Inc. to test a new device’s ability to kill pathogens — even the celestial kinds.
New tuberculosis drug regimen slashes treatment time
Tuberculosis is an age-old respiratory scourge, with a new twist: growing resistance to multiple first- and second-line drugs. UF researchers and physicians report on using a novel treatment to slash…
UF study reveals how Chlamydia acquires essential nutrients
New work from the lab of Tony Maurelli, associate chair of the department of environmental and global health in UF’s College of Public Health and Health Professions, has solved a…
